What does Collective Acquisition Corp. do?
A public acquisition vehicle, not an operating company
Collective Acquisition Corp. is a Cayman Islands SPAC whose Class A shares trade on Nasdaq under CCAQ. It seeks a private business for a merger, share exchange, asset purchase, reorganization, or similar transaction that creates a public operating company. The official company page identifies it as a blank check company.
CCAQ has no products, customers, operating revenue, or conventional business divisions. Its resources are the trust cash, the sponsor team's transaction network, the public listing, and the ability to propose a business combination. At March 31, 2026, it had not commenced operations and expected no operating revenue before a transaction closes.
Securities and capital structure
| Security | Ticker / quantity | Economic role | Key term |
|---|---|---|---|
| Class A ordinary shares | CCAQ / 14.482813M issued at May 12, 2026 | Includes 14.375M redeemable public shares and 107,813 representative shares | Public shares may be redeemed under specified transaction, amendment, or liquidation events |
| Class B founder shares | 5.750M at March 31, 2026 | Sponsor economics and voting influence before a business combination | Generally convert one-for-one into Class A shares, subject to adjustment |
| Public warrants | 10.78125M at March 31, 2026 | Potential post-transaction equity upside and dilution | Each whole warrant is exercisable at $11.50 per Class A share |
| Private placement warrants | 2.000M at March 31, 2026 | Sponsor-financing instrument | Purchased at $1.00 per warrant in the IPO private placement |
How does CCAQ make money before a merger?
Revenue and cost mechanics
Before a business combination, Collective Acquisition Corp. does not earn sales revenue. Its reported income comes primarily from interest on marketable securities held in the trust account, while its expenses consist mainly of legal, accounting, audit, listing, consulting, due-diligence, and administrative costs. The Form 10-Q for the quarter ended March 31, 2026 reports one operating segment and identifies interest income and general and administrative costs as the measures management reviews.
How transaction economics work
The sponsor's return differs from the public shareholder's return. Founder shares were issued for nominal capital and may become valuable after a closing, while public investors retain redemption rights tied to the trust. Warrants add upside and dilution if a deal succeeds but expire worthless if no combination occurs. That asymmetry makes conflicts and dilution central to the analysis.
What does the latest reported period show?
Q1 2026 snapshot
| Metric | Q1 2026 / March 31, 2026 | Interpretation |
|---|---|---|
| Operating revenue | $0 | Expected for a pre-combination SPAC; operating-company revenue analysis is not yet applicable. |
| Loss from operations | $(585,975) | Search and public-company costs exceeded operating revenue, which remained zero. |
| Trust interest income | $1,300,569 | Non-operating interest more than offset the quarterly operating loss. |
| Net income | $714,594 | Accounting profit reflects interest-rate carry, not an operating franchise. |
| Operating cash used | $(281,544) | Cash burn outside trust remains the practical liquidity constraint. |
| Shareholders' deficit | $(6,046,436) | The deficit is heavily affected by redeemable-share accounting and should not be read like ordinary industrial book value. |
Annual baseline versus the latest quarter
Q1 shows a typical SPAC pattern: the trust grew and accounting earnings were positive, but unrestricted cash declined. The real question is whether CCAQ can convert its listing and trust capital into a high-quality transaction before redemptions, expenses, and time narrow the opportunity.
Why is the trust account the center of CCAQ's financial story?
Redemption economics and trust growth
The trust account protects public investors by segregating most IPO proceeds for a business combination, permitted redemptions, or liquidation. At December 31, 2025, the trust held $147.911 million, equal to about $10.29 per public share. At March 31, 2026, it held $149.211 million, or about $10.38 per redeemable public share. The July 2026 extension proxy estimated approximately $150.5 million at June 30 and about $10.47 per public share for the meeting. The July 8, 2026 proxy statement also disclosed that the board was in serious discussions with a potential target, but it did not identify the target or disclose transaction terms.
Liquidity outside the trust
Search, diligence, legal, and reporting costs are paid outside the trust. At March 31, 2026, CCAQ had $84,207 of cash and a $114,632 working-capital surplus, and its filing raised substantial doubt about going-concern liquidity. On July 17, the sponsor provided an unsecured, non-interest-bearing note of up to $500,000. The July 17, 2026 Form 8-K allows conversion at $1.00 per private warrant, creating potential dilution.
Which turning points define CCAQ's current strategy?
-
September 2024Dune Acquisition Corporation II was incorporated in the Cayman Islands as a transaction vehicle.
-
May 2025The 14.375M-unit IPO raised $143.75M gross, and $144.109375M entered the trust with private-placement funding.
-
January-February 2026The new sponsor acquired 4.475M founder shares and 1.0M private warrants for $2.0M, replacing the transaction leadership.
-
April 2026Richmond became chairman, Bailin and Sziklay became independent directors, and shareholders approved the Collective name. The April 2026 Form 8-K records the transition.
-
July 2026The company disclosed serious discussions with a potential target, proposed extending the transaction deadline from August 8, 2026 to August 8, 2027, and arranged up to $500,000 of sponsor financing.
-
July 17, 2026Maximilian Staedtler was appointed chief financial officer, while Elliot Richmond continued as chairman and chief executive officer. This separated the CEO and CFO functions during an active transaction period.
Why the sponsor handover changed the thesis
A sponsor transfer matters because management's network, judgment, financing access, and reputation are core SPAC resources. The new sponsor acquired most founder shares and one million private warrants; the old sponsor retained 1.275 million founder shares. Richmond brings investment-banking and SPAC experience, Bailin institutional investment expertise, and Sziklay fund-management, technology, finance, and legal experience.
The transition increases the relevance of execution quality. A new team can refresh deal flow and credibility, but it also inherits a fixed legal structure, a finite deadline, deferred fees, public warrants, and shareholders who can redeem. The target ultimately selected will determine whether the sponsor handover created durable value or merely extended the life of the vehicle.
How does CCAQ compete for a business combination?
Target selection criteria
CCAQ may pursue a target in any industry or at any stage of development. Its annual report emphasizes experienced management, growth potential, competitive positioning, and the ability to benefit from public capital. Nasdaq rules require the initial business combination to have an aggregate fair market value of at least 80% of the assets held in trust, excluding specified deferred fees and taxes, when the agreement is signed. The company may use cash, shares, debt, or a combination, and it expects to seek businesses larger than the cash available in trust when additional financing or seller equity can bridge the difference.
Competition is for attractive private companies
| Competing route | Why a target may prefer it | CCAQ's possible response |
|---|---|---|
| Other SPACs | Alternative sponsor teams, larger trusts, different sector expertise, or more committed financing | Offer sponsor experience, flexible consideration, and a negotiated public-market path |
| Private equity and leveraged-buyout funds | Execution certainty, private governance, operational resources, and committed capital | Offer public equity currency, liquidity, and access to future capital markets |
| Strategic acquirers | Synergies, established distribution, technology integration, or lower financing risk | Provide an independent public platform and potentially greater seller participation |
| Traditional IPO | Broad price discovery, conventional governance, and potentially lower sponsor dilution | Offer negotiated valuation and transaction structure, subject to shareholder redemption and financing conditions |
The 2025 Form 10-K identifies other SPACs, private equity, buyout funds, public companies, and strategic buyers as competitors. CCAQ's potential advantage is its listing, trust capital, structuring flexibility, and management relationships, provided the selected target withstands diligence and redemption pressure.
Who controls CCAQ, and why does governance matter?
Board and management after the July change
As of July 17, 2026, Elliot Richmond served as chairman and chief executive officer, Maximilian Staedtler served as chief financial officer, and David Bailin and Jeremy Sziklay served as independent directors. Bailin and Sziklay had also been appointed to the audit and compensation committees. The board structure is compact, which can speed decision-making but concentrates transaction oversight in a small group. The Nasdaq listing of the Class A shares is confirmed on the official Nasdaq page for CCAQ.
Beneficial ownership and incentives
| Holder / group | Shares | Approximate stake | Why it matters |
|---|---|---|---|
| Collective Acquisition Sponsor / Elliot Richmond | 4,475,000 founder shares | 22.10% attributed to the officers-and-directors group | The sponsor has substantial voting influence and strong economic motivation to complete a transaction. |
| Dune Acquisition Holdings II | 1,275,000 | 6.30% | The old sponsor retained a meaningful founder-share position after the handover. |
| Aristeia Capital | 1,100,000 | 5.44% | A significant public-market holder can influence voting and redemption dynamics. |
| Tenor parties | 1,000,000 | 4.94% | The position is below 5% in the proxy calculation but remains relevant to event-driven ownership. |
| Magnetar parties | 850,000 | 4.20% | Another concentrated holder whose redemption or voting decision may affect transaction cash. |
Sponsor economics create alignment and conflict. A deal can make founder shares and private warrants valuable; liquidation can make them worthless. That motivates completion but may make a marginal deal more attractive to the sponsor than to a shareholder able to redeem near trust value. Independent oversight, disclosure, voting, and redemption rights are therefore substantive protections.
What opportunities could improve CCAQ's outcome?
The opportunity set is broad but undefined
CCAQ is not limited to a sector, geography, or maturity stage. The approximately $150.5 million trust can support a meaningful transaction, while equity, debt, seller rollover, private placements, or backstops could expand purchasing capacity. A target may value the ability to negotiate consideration, governance, and capital structure directly.
What should researchers monitor next?
If the extension is approved, the sponsor would contribute monthly the lesser of $35,000 or $0.02 per outstanding public share as loans until the extended deadline, an earlier deal, or wind-up. The amount is modest relative to the trust but compensates investors for time and may support diligence, financing, SEC review, and closing.
What risks could weaken the structure?
Sponsor incentives and dilution
| Risk | Current factual anchor | Financial consequence to monitor |
|---|---|---|
| Deadline and liquidation | Current deadline is August 8, 2026; extension vote is scheduled for August 4, 2026 | Failure to extend or close leads toward redemption, dissolution, and worthless warrants. |
| Redemptions | 14.375M public shares have redemption rights | Cash delivered to the target can fall sharply, raising financing needs or preventing closing. |
| Sponsor conflict | 4.475M founder shares are attributed to the officers-and-directors group | The sponsor may prefer completing a deal over liquidation even when public investors are less enthusiastic. |
| Warrant dilution | 12.78125M public and private warrants were outstanding at March 31, 2026 | A successful post-deal share price can trigger dilution and affect per-share value. |
| Outside-trust liquidity | $84,207 cash at March 31, 2026; sponsor note up to $500,000 dated July 17, 2026 | Search and transaction costs may require additional sponsor support or convertible financing. |
| Regulatory burden | The SEC's 2024 SPAC rules require enhanced sponsor, conflict, dilution, and target disclosures | Longer review, higher professional fees, and more demanding transaction documentation. |
The SEC's 2024 SPAC rule announcement emphasizes sponsor compensation, conflicts, dilution, projections, and de-SPAC disclosure. CCAQ says the rules may increase transaction costs and timing. It must also maintain Nasdaq compliance, avoid investment-company status, manage cybersecurity and vendor claims, and address approvals relevant to the eventual target.
Deadline, execution, and target risk
These are analytical summaries, not credit ratings. Investors still cannot evaluate the future operating company. The target could be cyclical, unprofitable, leveraged, overvalued, projection-dependent, or heavily regulated. Until transaction documents are filed, target quality remains the largest unknown.
Why does CCAQ matter for valuation?
A DCF requires operating forecasts for revenue, margins, taxes, capital expenditure, working capital, and terminal value. CCAQ has none before a merger. Its income is trust interest, while operating cash flow is negative because it is searching for a transaction. Applying an earnings multiple to Q1 2026 net income would mischaracterize the vehicle.
| Valuation layer | Current CCAQ anchor | What changes after a deal is announced |
|---|---|---|
| Trust value | Approximately $10.47 per public share estimated for the August 2026 meeting | Redemption economics remain relevant, but the combined-company equity value becomes central. |
| Transaction valuation | Not disclosed as of July 8, 2026 | Enterprise value, seller rollover, debt, cash, and financing commitments can be analyzed. |
| Operating forecast | Not applicable to the shell | Target revenue growth, margins, reinvestment, and free cash flow become the DCF drivers. |
| Dilution | Founder shares, 10.78125M public warrants, 2.0M private warrants, and possible sponsor-note warrants | Fully diluted shares must include merger consideration, warrants, earnouts, PIPE securities, and incentive equity. |
| Closing probability | Extension and definitive agreement remain pending | Regulatory approvals, shareholder vote, redemptions, minimum cash, and financing conditions determine completion risk. |
The eventual target will reset every key metric
Once a target is disclosed, analysts should rebuild the model from transaction documents rather than extrapolate CCAQ's statements. Bridge enterprise value to pro forma equity value by adjusting for debt, delivered cash, fees, seller rollover, financing, and fully diluted shares. A DCF can then test the negotiated valuation against target cash flows.
What is the key takeaway from Collective Acquisition Corp. analysis?
Collective Acquisition Corp. is a time-limited transaction platform. Its strongest asset is the approximately $150.5 million trust balance at June 30, 2026; its strategic resource is the sponsor and board's deal-making experience. The near-term focus is the potential target discussion and proposed extension from August 8, 2026 to as late as August 8, 2027.
The structure contains clear tensions. Public holders can redeem near trust value, while low-cost founder shares gain value after a closing. Trust interest produces accounting income, but unrestricted cash is limited and required a sponsor note of up to $500,000. Warrants, founder shares, and transaction financing can materially dilute post-combination ownership.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.